Note:  This event has been recorded and may be viewed here

PA3 INVITES YOU TO “SECOND TUESDAYS”

A PRINCETON PROPELLER ZOOM EVENT

UWMA @ QUADRANGLE CLUB

FOR ENTREPRENEURS,
NAVIGATORS & THE CURIOUS
Please Join Us with Cocktails & Hors d’oeuvres

WHEREVER YOU ARE

7 P, EASTERN TIME (USA) -- TUESDAY, November 9th, 2021

“Combining Cell Fate Reprogramming & Immunotherapy: A Revolutionary Approach for Cancer Treatment”

Speaker: Filipe Pereira, PhD

Founder & Head of Innovation, Asgard Therapeutics

Associate Professor, Lund University

Cancer is the second-leading cause of human death, with more than 10 million lives lost annually and a cost
burden topping 1 trillion USD worldwide. For the 80 percent of tumors that are solid and hard-to-treat, current
standards of care (surgery, radiotherapy, chemotherapy) are often inadequate. Even the newer approaches of
modern immunotherapy (immune checkpoint inhibitors, CAR T-cell therapies, cancer vaccines) often fall short
in more than half of patients, due to lack of antigen presentation, tumor heterogeneity, and immune evasion.
ENTER: a new gene therapy for cancer based on cellular reprogramming, co-developed by our speaker. This
technology reprograms cancer cells into dendritic cells that present their own tumor antigens for destruction.
Following background on ways to reprogram cells, our speaker will: detail his current work; provide previously
unpublished data; touch on challenges that remain before first-in-human trials can take place; and mull
prospects for cell fate reprogramming to transform the current cancer immunotherapy landscape.

To receive the Zoom link, please register by November 7th:   propellers.princetonaaa.org

NEXT PRINCETON PROPELLER: Tuesday, February 8th, 2022 (7 P)